CLOV 8-K & SEC Filings - Yahoo Finance

Clover Health (CLOV) filed an 8-K with the SEC, detailing corporate changes and voting matters. The filing includes exhibits and is available on the SEC's website. The specific details of the changes were not provided in the summary.

Original reporting
Published Nov 5, 2026, 4:47 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 7:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CLOV
Neutral
medium confidence
Mentioned
$CLOV
Relevance
5/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$CLOVNeutralLow
01

Why it matters

The filing signals a corporate event that may affect investor sentiment pending detail release.

02

Market read

Primary corporate filing with modest trading relevance; investors may watch for details.

03

What to watch

Potential hidden changes to board composition or share structure.

Relevance 5/10Novelty 5/10Timing: today

Background

The article is a scraped placeholder that only lists the 8‑K filing title for Clover Health (CLOV).

Company-level read

Ticker impact

$CLOVNeutralMedium confidence
Context

SEC 8‑K filing reports corporate changes and voting matters for Clover Health.

Expected impact

potential pressure as market prices in the disclosed changes

Evidence & confidence

8‑K filings often move the stock modestly until details are known.

Market effects

Limited; corporate governance news may affect other health‑tech peers.

U.S. market only.

Low

Counterpoint

The filing could be a routine update with no material impact.

Key entities

  • Clover Health

    U.S. listed health‑tech firm filing an 8‑K.

Related articles

$UNHMed

Medicare, Medicaid Overhaul Targets Fraudulent Billing and Unauthorized Marketplace Enrollments

CMS proposed reforms to combat fraud in Medicare, Medicaid, CHIP, and the Health Insurance Marketplace, aiming to save $90B over 10 years. The rule strengthens oversight, requires self-reporting of overpayments, and increases transparency. Managed care stocks fell, including UNH, HUM, CVS, CLOV, CNC, MOH, ELV, and OSCR. Medicare anti-fraud efforts saved $41.9B in 2025, with a $22.30 return per dollar spent.

$HUMHighAI 9/10

Humana (HUM) Stock Hits New 52-Week High

Humana (HUM) reached a new 52-week high after reporting Q3 2026 earnings with a smaller loss and raised full-year EPS guidance. Competitors like CVS Health and Elevance Health also saw gains. Clover Health (CLOV) reported Q3 2026 earnings with a slight profit and raised full-year targets.

$CLOVHighAI 8/10

Clover Health (CLOV) Q3 2026 Earnings Call Transcript

Clover Health (CLOV) reported Q3 2026 earnings, highlighting 49% YoY membership growth to 157,000 members, 57% revenue increase to $2.3B, and doubled adjusted EBITDA to $97M. The company achieved high Star Ratings for its plans and improved HEDIS quality performance. Clover Assistant's engagement accelerated, driving better care and economics. The board appointed Clay Thornton as permanent CFO. Management expects continued growth and profitability in 2027 and 2028.